Three drugmakers settle with California over deals to keep generic medications off the market

 In breaking

Teva maintained a monopoly over sales of a narcolepsy drug by entering “pay-for-delay” deals to delay a generic version for six years, Atty. Gen. Xavier Becerra’s office said.

from California

Recent Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search